Sylvain Ferrandon
The Ohio State University Wexner Medical Center(US)The Ohio State University(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Colorectal Cancer Treatments and Studies, Gut microbiota and health, Cancer, Lipids, and Metabolism, Cancer Research and Treatments
Most-Cited Works
- → Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 Signaling(2021)184 cited
- → Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity(2021)106 cited
- → CoA Synthase ( COASY ) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer(2019)48 cited
- → MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma(2016)40 cited
- → Telomere Profiling: Toward Glioblastoma Personalized Medicine(2012)33 cited
- → Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma(2015)33 cited
- → Simvastatin enhances radiation sensitivity of colorectal cancer cells(2017)27 cited
- → Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing(2016)27 cited
- → Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers(2018)24 cited
- → Poly(ADP-Ribose) Polymerase Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy(2018)24 cited